blog

Bonus Content: COVID-19 and Beyond Virtual Town Hall

By Elizabeth Gargill on Tue, May 26, 2020 | 2 min read

More of Your Questions Answered

In this special video clip, industry innovators Aaron Fleishman and Craig Lipset answer some of the overflow questions from our Virtual Town Hall on maintaining clinical trial momentum during COVID-19 and beyond.

This 20-minute segment features answers to your questions relating to:

  • Implementation of decentralized trials
  • Impact of COVID-19 on enrollment of healthy volunteers
  • Biggest concerns for clinicians around remote contact with patients
  • Advancing decentralized trials while not leaving behind people without access to reliable internet, electronic devices, or digital savvy
  • Validating new digital endpoints for decentralized trials
  • Impact of telemedicine and other decentralized trial approaches on  monitoring and source data verification (SDV)

 

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Watch Now: COVID-19 and Beyond Virtual Town Hall

By Elizabeth Gargill on Tue, May 19, 2020 | 1 min read

Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.

Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

"COVID-19 and Beyond" Virtual Town Hall

By Elizabeth Gargill on Wed, May 6, 2020 | 1 min read

"COVID-19 and Beyond" Virtual Town Hall - May 14, 2020 @ 12:00 p.m. ET

Join industry innovators Craig Lipset and Aaron Fleishman for a virtual town hall to discuss maintaining clinical trial momentum during COVID-19 and beyond. Register now.

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

What and When to Submit to the IRB?

By Elizabeth Gargill on Wed, Apr 29, 2020 | 1 min read

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

Topics: Patient Engagement, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

By Elizabeth Gargill on Thu, Apr 23, 2020 | 1 min read

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Topics: Patient Engagement, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

Ramping Up Patient & Site Engagement during COVID-19

By Elizabeth Gargill on Tue, Apr 14, 2020 | 6 min read

 

Guidance to Help Respond to Immediate Challenges 

As the COVID-19 outbreak challenges clinical trial sponsors, we’ve identified efforts to support patient and site engagement -  helping to minimize clinical trial disruption and keep timelines intact. Some efforts respond to FDA guidance on conducting clinical trials during the COVID-19 pandemic while others respond to challenges introduced by travel restrictions, infection risks, enhanced site burden, and protocol deviations.

Topics: Patient Engagement, Site Engagement, RSG Arrive, COVID-19

Minimizing Clinical Trial Disruption from COVID-19

By Elizabeth Gargill on Thu, Apr 2, 2020 | 2 min read

 

We are closely monitoring the COVID-19 outbreak and its impact on clinical trial patient recruitment, engagement, and compliance. As the health and wellbeing of patients remains our priority, we’ve outlined key solutions clinical trial sponsors can quickly deploy to enhance compliance and ensure patients are able to continue with their clinical trial participation.

Topics: Patient Engagement, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

5 Innovations Shaking Up Clinical Trial Patient Recruitment

By Elizabeth Gargill on Tue, Mar 10, 2020 | 4 min read

 

For clinical trial sponsors, staying on top of the latest innovations can be a challenge, especially in an industry historically slow to adapt to change. But experts warn of the risk of falling behind, especially in light of advancing technologies that are impacting clinical trial enrollment and engagement.

While you may not be ready to embrace the use of a virtual self-service hologram—greeting patients in the doctor’s office with information about a clinical trial—there are a few key innovations that all clinical trial sponsors should keep on their radar. Below, we highlight three that are driving significant change.

 

Topics: Wearables, Patient Experience, Voice Assistants, Patient Portals, Call Centers, At-home Visits, Clinical Trial Innovations

Latest “Study Voices” Survey Finds Unexpected Similarities Between Healthcare Consumers and Clinical Trial Participants

By Elizabeth Gargill on Thu, Feb 20, 2020 | 3 min read

 

Survey Results Empower Clinical Trial Sponsors with New Opportunities for Patient Engagement

Our latest "Study Voices" survey challenges the long-held belief that the clinical trial experience should be approached differently than the healthcare consumer experience. The latest “Study Voices” survey – part of an ongoing series of surveys designed to shed light on key clinical research trends – explores patient attitudes towards technology,  healthcare affordability, physician access, transparency, and quality of care. It features responses from 2,067 individuals – 63% of whom identify themselves as healthcare consumers and 38% of whom identify themselves as clinical trial participants. The research was spearheaded by BBK's MythBusters team of Aaron Fleishman, Matt Kibby, Jessica Kim, Maddy Johnson and Elizabeth Gargill.

Topics: Study Voices, MythBusters, Healthcare Consumer, Clinical Trial Participant

BBK Worldwide Bolsters Its Award-Winning Creative Department with the Hiring of Pedro Giesta as Designer

By Elizabeth Gargill on Mon, Feb 10, 2020 | 1 min read

 

We're very pleased to announce the hiring of Pedro Giesta as designer. With a talent for cutting-edge creative and insightful design, Giesta joins a team of award-winning designers and copywriters who push the industry forward with innovative and imaginative solutions. In his new position, Giesta will support concept development through creative execution – leveraging his experience as a studio artist, production artist, and graphic designer in the process.

Topics: Creative, Design, Employees

 
Subscribe To Our Blog